Join steering committee for Drug-Drug Interaction Partnership Research Project
Deadline: Saturday, 28 September 2019
Who: University of Sydney, Charles Perkins Centre: National Health and Medical Research Council Drug-Drug Interaction Partnership Project Steering Committee
Despite the absence of robust evidence of effectiveness, enormous resources continue to be devoted to implementing decision support for clinicians in electronic medication management (eMM) systems to reduce drug-drug interactions (DDIs).
Although computerised alerts sound promising in principle, in reality prescribers are often bombarded with large numbers of alerts. The consequence is alert fatigue, where users become overwhelmed and desensitised to alert presentation, so much so that alerts are ignored.
As medication management in Australian hospitals shifts from paper to electronic formats, organisations are faced with a difficult decision: should DDI alerts be turned on and if so, which alerts? Such decisions should be informed by evidence which demonstrates that alerts align well with prescriber workflow, are effective in reducing errors and result in reduced patient harm. This research project aims to provide this evidence.
The National Health and Medical Research Council (NHMRC) Drug-Drug Interaction Partnership Project Steering Committee is looking for health consumer representatives who would like to join the committee. The committee meets twice a year until the end of 2021. The next meeting is scheduled for November 2019. Steering committee members do not have to attend the meeting in person. Members are able to attend by phone or by using Zoom meeting. Travel expenses and a sitting fee of AUD 196.47 per meeting will be paid. Health consumer representatives should have experience and/or interest in E-Health. Other committee members are academics from the University of Sydney and Macquarie University, site investigators from Local Health Districts, and representatives from eHealth NSW and eHealth Queensland.
If you are interested in joining the committee as a health consumer representative, please contact Wu Yi Zheng, Postdoctoral Research Associate, University of Sydney on (02) 8627 9248 or 0422 510 718 or email: email@example.com.